학술논문

A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER plus ) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2020, 31 pS1160-pS1160, 1p. Supplement: 4
Subject
Language
English
ISSN
15698041